Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the guideline development subcommittee of the American academy of neurology

Neurology

Volumn 80, Issue 22, 2013, Pages 2065-2069

  Armstrong, Melissa J ^a   Gronseth, Gary ^b   Anderson, David C ^c   Biller, José ^d   Cucchiara, Brett ^e   Dafer, Rima ^f   Goldstein, Larry B ^g   Schneck, Michael ^h   Messé, Steven R ^e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Medicine Elizabeth Heywood   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CATARACT EXTRACTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COLONOSCOPY; DENTAL PROCEDURE; DERMATOLOGICAL PROCEDURE; ELECTROMYOGRAM; ENDOSCOPY; EVIDENCE BASED PRACTICE; HUMAN; LUNG BIOPSY; POLYPECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE BIOPSY; SAPHENOUS VEIN; SPHINCTEROTOMY; SYSTEMATIC REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT WITHDRAWAL;

BRAIN ISCHEMIA; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HUMANS; NEUROLOGY; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; STROKE;

EID: 84879493996     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318294b32d     Document Type: Article

References (7)

1. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010;104:305-312.
2. Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol 2005;62:1217-1220.
3. Garcia Rodriguez LA, Cea Soriano L, Hill C, Johansson S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology 2011;76:740-746.
4. Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008;168:63-69.
5. Repchinsky C, ed. CPS 2009 Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacists Association; 2009.
6. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed). Chest 2008;133:299S-339S.
7. Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001;323:1218-1222.